Blockbuster sales, lawsuits, and approvals: is there a recovery in sight for Bayer in 2026?
Roohi Mariam Peter
Bayer has a lot on its plate; lawsuits, patent cliffs, drug development, and potential FDA approvals. Is it ready to make a comeback in 2026? The post Blockbuster sales, lawsuits, and approvals: is there a recovery in sight for Bayer in 2026? appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provid